The IL-33/serum stimulation-2 (ST2) axis has been shown to have a detrimental effect on rheumatoid arthritis, systemic lupus erythematosus, and other rheumatic diseases. The gene discussed is IL1RL1; the disease is systemic lupus erythematosus.